I/ONTAKis our leadassetWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI/ONTAK'spotentialmarket is>$300mMino-WrapNot manycompaniesthis size with2 late stageassetsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.There are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamWe willhaveexclusivityThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Insidersinvested$26.5mI won't diluteshareholdersI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022Myron Holubiakand I founded aprivatecompany in2013Mino-Lokis our leadassetWe had aphase 2btrial with100%efficacyHemorrhoidsis a $2BmarketI/ONTAKis our leadassetWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI/ONTAK'spotentialmarket is>$300mMino-WrapNot manycompaniesthis size with2 late stageassetsI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.There are noFDAapproveddrugs to treathemorrhoidsAn actualiMSCupdateWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamWe willhaveexclusivityThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Insidersinvested$26.5mI won't diluteshareholdersI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022Myron Holubiakand I founded aprivatecompany in2013Mino-Lokis our leadassetWe had aphase 2btrial with100%efficacyHemorrhoidsis a $2Bmarket

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK is our lead asset
  2. We have enough cash to go well into 2023
  3. We will open up international sites for Mino-Lok trial
  4. I/ONTAK's potential market is >$300m
  5. Mino-Wrap
  6. Not many companies this size with 2 late stage assets
  7. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  8. There are no FDA approved drugs to treat hemorrhoids
  9. An actual iMSC update
  10. We expect to finish the Mino-Lok trial this year
  11. I'm a shareholder myself
  12. We intend to submit a BLA in 2H 2022
  13. Mino-Lok potential market >$1B
  14. Only biotech with 2 Myron's on the leadership team
  15. We will have exclusivity
  16. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  17. Insiders invested $26.5m
  18. I won't dilute shareholders
  19. I/ONTAK was the best deal I ever made
  20. Our Halo-Lido trial will have final patient by end of 2022
  21. Myron Holubiak and I founded a private company in 2013
  22. Mino-Lok is our lead asset
  23. We had a phase 2b trial with 100% efficacy
  24. Hemorrhoids is a $2B market